|
| Press Releases |
|
 |
|
| Tuesday, June 25, 2019 |
|
|
Jacobson Pharma Announces FY2019 Annual Results |
| Jacobson Pharma Corporation Limited ("Jacobson Pharma" or the "Company"; Stock Code: 2633), a leading company engaged in the research, development, production, marketing and sale of generic drugs and proprietary medicines, today announced its annual results of the Company and its subsidiaries (collectively the "Group") for the year ended 31 March 2019 (the "FY2019"). more info >> |
|
| Wednesday, May 8, 2019 |
|
|
Jacobson Pharma and Yunnan Baiyao Group to Continue Exploring Further Possibilities of Business Cooperation and Other Collaborations |
| Jacobson Pharma Corporation Limited ("Jacobson Pharma" or the "Group"; Stock Code: 2633), a leading company engaging in the research, development, production, marketing and sale of generic drugs and proprietary medicines, has been informed by Yunnan Baiyao Holdings Company Limited1 ("Baiyao Holdings") and Yunnan Baiyao Group Co.,Ltd. more info >> |
|
| Thursday, May 2, 2019 |
|
|
Jacobson Pharma Issues Positive Profit Alert |
| Jacobson Pharma Corporation Limited ("Jacobson Pharma" or the "Company"; Stock Code: 2633), a leading company engaging in the research, development, production, marketing and sale of generic drugs and proprietary medicines, has today announced a positive profit alert. more info >> |
|
| Wednesday, November 21, 2018 |
|
|
Jacobson Pharma Announces FY2019 Interim Results |
Jacobson Pharma Corporation Limited ("Jacobson Pharma" or the "Company"; Stock Code: 2633), a leading company engaged in the research, development, production, marketing and sale of generic drugs and proprietary medicines, today announced its unaudited interim results of the Company and its subsidiaries (collectively the "Group") for the six months ended 30 September 2018 (the "reporting period").
more info >> |
|
| Monday, June 25, 2018 |
|
|
Jacobson Pharma Announces 2018 Annual Results |
| Jacobson Pharma Corporation Limited ("Jacobson Pharma" or the "Group"; Stock Code: 2633), a leading company engaged in the research, development, production, marketing and sale of generic drugs and proprietary medicines, today announced its annual results of the Company and its subsidiaries (collectively the "Group") for the year ended 31 March 2018 ("FY2018"). more info >> |
|
|
Jacobson Pharma Announces 2018 Annual Results |
Jacobson Pharma Corporation Limited ("Jacobson Pharma" or the "Group"; Stock Code: 2633), a leading company engaged in the research, development, production, marketing and sale of generic drugs and proprietary medicines, today announced its annual results of the Company and its subsidiaries (collectively the "Group") for the year ended 31 March 2018 ("FY2018").
more info >> |
|
| Thursday, June 14, 2018 |
|
|
Jacobson Pharma Updates on TAILORx Study |
| Jacobson Pharma Corporation Limited ("Jacobson Pharma" or the "Group"; Stock Code: 2633), the Hong Kong and Macau exclusive distributor of Genomic Health, Inc. (NASDAQ: GHDX), the world's leading provider of genomic-based diagnostic tests, is pleased to share that the Trial Assigning IndividuaLized Options for Treatment (Rx), or TAILORx, successfully defined the benefit of chemotherapy in early-stage breast cancer patients with Oncotype DX Breast Recurrence Score(R) results of 11 to 25. more info >> |
|
| Wednesday, June 13, 2018 |
|
|
Jacobson Pharma Updates on TAILORx Study |
| Jacobson Pharma Corporation Limited ("Jacobson Pharma" or the "Group"; Stock Code: 2633), the Hong Kong and Macau exclusive distributor of Genomic Health, Inc. (NASDAQ: GHDX), the world's leading provider of genomic-based diagnostic tests more info >> |
|
| Tuesday, April 17, 2018 |
|
|
Jacobson Pharma Ranked No.1 in "Hong Kong Best Small-Cap Company" in the "Asia's Best Companies Poll 2018" by FinanceAsia |
| Jacobson Pharma Corporation Limited ("Jacobson Pharma" or the "Group"; Stock Code: 2633), a leading company engaged in the research, development, production, marketing and sale of generic drugs and proprietary medicines, is pleased to announce that Jacobson Pharma ranked no.1 in the category of Hong Kong Best Small-Cap Company in the "Asia's Best Companies Poll 2018" conducted by FinanceAsia, an authoritative financial magazine in Asia. more info >> |
|
|
Jacobson Pharma Ranked No. 1 in "Hong Kong Best Small-Cap Company" in the "Asia's Best Companies Poll 2018" by FinanceAsia |
| Jacobson Pharma Corporation Limited ("Jacobson Pharma" or the "Group"; Stock Code: 2633), a leading company engaged in the research, development, production, marketing and sale of generic drugs and proprietary medicines, is pleased to announce that Jacobson Pharma ranked no.1 in the category of Hong Kong Best Small-Cap Company in the "Asia's Best Companies Poll 2018" conducted by FinanceAsia, an authoritative financial magazine in Asia. more info >> |
|
|
|
|
|
|
|
|
 |
| Latest Press Releases |
|
TechInnovation 2025 Returns with 3 Days of Game-Changing Innovation
Aug 28, 2025 14:27 HKT/SGT
|
|
|
CALB (3931.HK) Announces 2025 Interim Results
Aug 28, 2025 11:00 HKT/SGT
|
|
|
Poolbetx Token (PBX) - The World's First Crypto i-Gaming Digital Chip 
Aug 28, 2025 10:00 HKT/SGT
|
|
|
Shuangdeng Group Listed on the Main Board of the Hong Kong Stock Exchange
Aug 28, 2025 08:28 HKT/SGT
|
|
|
CaoCao Inc. announced 2025 Interim Results: Revenues Surged 53.5% Year-on-Year to RMB 9.5 Billion, Gross Profit Margin increased to 8.4%
Aug 28, 2025 08:23 HKT/SGT
|
|
|
NEC develops AI technology for digitalizing work tasks without the need for pre-training and utilizing video from multiple cameras covering wide area worksites
Aug 27, 2025 22:57 JST
|
|
|
CIMC Group Announces 2025 Interim Results
Aug 27, 2025 21:50 HKT/SGT
|
|
|
Result of the Business Plan Review for the Offshore Wind Power Generation Projects in Japan
Aug 27, 2025 22:27 JST
|
|
|
Formerra Appointed Distributor for Italy's Epaflex TPU Lines in the UK & Ireland
Aug 27, 2025 21:00 HKT/SGT
|
|
|
Fujitsu develops AI agent platform for the healthcare sector to enhance operational efficiency and ensure stable medical service provision
Aug 27, 2025 21:50 JST
|
|
|
MHI Becomes First Japanese Company to Acquire ISO 19443:2018 Certification in the Nuclear Energy Field
Aug 27, 2025 21:32 JST
|
|
|
T-RIZE and Republic Launch 'Vision 60' to Expand Institutional Access to Tokenized Real Estate
Aug 27, 2025 20:00 HKT/SGT
|
|
|
Mitsubishi Logisnext to Demonstrate Automated Forklift Equipped with "SynfoX" at "4th INNOVATION EXPO"
Aug 27, 2025 20:59 JST
|
|
|
Belt and Road Summit Returns in September
Aug 27, 2025 19:17 HKT/SGT
|
|
|
'Fate War' Achieves Gross Billing of HK$20 million in Three Weeks, Resilient Interim Results with Total Dividends of HK13.9 cents per Ordinary Share Declared
Aug 27, 2025 18:11 HKT/SGT
|
|
|
|
|
More Press release >> |
|
|
|
|
|
|
|
